Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioelectronics-corp-biel-2953.html Mr. Whelan explained the science of bioelectronics, the chronic pain market, the far-reaching … Continue Reading
Category
News
Bioelectronics Compay Update April 7, 2016
BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget” The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. A panel of six independent over-the-counter marketing experts evaluated the seven … Continue Reading
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results
61% Pain Reduction & Decreases Medication Use in 86% (including opioids) FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of the drug-free over-the-counter, $30.00 ActiPatch® (www.actipatch.com) Musculoskeletal Pain Therapy medical devices, announced today the completion of a 6-month ActiPatch product observation study conducted in conjunction with its ongoing market … Continue Reading
BioElectronics Appoints Evomed as Australian and New Zealand Distributor
FREDERICK, MD. March 21, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole™ Heel Pain Relief Therapy in Australia and New Zealand. Evomed specializes in the … Continue Reading
BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget”
FREDERICK, MD. March 15, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. … Continue Reading
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
FREDERICK, MD, USA, March 9, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that a research abstract featuring ActiPatch® will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the … Continue Reading
BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
FREDERICK, MD. Feb 18, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx).The UK drug tariff list establishes payment for prescription costs in the UK. “Orthopedic surgeons … Continue Reading
BioElectronics Corporation Refutes SEC Order for Administrative Proceedings
FREDERICK, Md., Feb. 8, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it is responding to a notice of an order for administrative proceedings from the Securities and Exchange Commission posted on the agency website. “Although neither the Company nor any of the respondents have been … Continue Reading
BioElectronics’ Innovative Chronic Pain Therapy Nominated for “Best OTC Marketing Campaign on a Small Budget”
FREDERICK, MD. February 1, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy product received an award nomination from the OTC Bulletin, the leading international trade publication for over-the-counter pharmacy products worldwide for “Best OTC Marketing Campaign on a Small Budget”. The … Continue Reading
BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis
FREDERICK, MD. January 5, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization¹ by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, … Continue Reading